Komori
Haba Laboratories (4925) · RiskRestated

Legal regulations and labeling requirements concerning cosmetics and food products

First written in FY2016. 26 of 27 entries say "Restated". Latest entry: FY2026.

27entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20262016: 320162017: 320172018: 420182019: 420192020: 420202021: 420212022: 220222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies

The whole theme swung hardest in 2021: 2 of 13 companies on the "Worse" side.

16 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 21 companies compared. The sentences above are computed from all 21.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Our group has established an internal review system for labeling content and works to ensure thorough compliance with laws and regulations, including by confirming matters with the relevant supervisory authorities as necessary.」

    The company continues to address the risks associated with laws and regulations, labeling and advertising restrictions concerning cosmetics and health foods through internal reviews and confirmation with the relevant supervisory authorities.
  2. FY2024-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  3. FY2023-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  4. FY2023-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  5. FY2022-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  6. FY2022-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  7. FY2022-Q1RestatedAnnual report

    「No new business or other risks arose during the first quarter of the current consolidated cumulative period. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  8. FY2021RestatedAnnual report

    「The cosmetics business is subject to regulations related to the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals, Medical Devices and Other Products (formerly the Pharmaceutical Affairs Law), which aims to ensure the quality, efficacy and safety of pharmaceuticals, quasi-drugs, cosmetics and other products.」

    The company continues to disclose the laws and regulations concerning the manufacture, sale and labeling of cosmetics and food products, as well as the practice of referring questionable labeling to the relevant supervisory authority.
  9. FY2021-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative first nine months of the consolidated fiscal year. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  10. FY2021-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  11. FY2021-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  12. FY2020RestatedAnnual report

    「The cosmetics business is subject to regulations under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, which aims to ensure the quality, efficacy and safety of pharmaceuticals, quasi-drugs, cosmetics and other products.」

    The company continues to disclose the laws and regulations concerning the manufacture, sale and labeling of cosmetics and food products, as well as the practice of referring questionable labeling to the relevant supervisory authority.
  13. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  14. FY2020-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  15. FY2020-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  16. FY2019RestatedAnnual report

    「The cosmetics business is subject to regulations under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, which aims to ensure the quality, efficacy and safety of pharmaceuticals, quasi-drugs, cosmetics and other products.」

    The company continues to disclose the laws and regulations concerning the manufacture, sale and labeling of cosmetics and food products, as well as the practice of referring questionable labeling to the relevant supervisory authority.
  17. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  18. FY2019-Q2RestatedAnnual report

    「During the second quarter consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  19. FY2019-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  20. FY2018RestatedAnnual report

    「The cosmetics business is subject to regulations under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, which aims to ensure the quality, efficacy and safety of pharmaceuticals, quasi-drugs, cosmetics and other products.」

    The company continues to identify compliance with laws and regulations concerning the manufacture, sale and labeling of cosmetics and food products as a business risk.
  21. FY2018-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  22. FY2018-Q2RestatedAnnual report

    「During the second quarter consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  23. FY2018-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  24. FY2017-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  25. FY2017-Q2RestatedAnnual report

    「During the second quarter consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  26. FY2017-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The disclosure states that there have been no new developments or material changes concerning legal regulations and labeling requirements for cosmetics and food products.
  27. FY2016First statedAnnual report

    「The cosmetics business is subject to regulations under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, which aims to ensure the quality, efficacy and safety of pharmaceuticals, quasi-drugs, cosmetics and other products.」

    The company must comply with the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, food-related laws, and laws concerning mail-order sales and misleading representations, and describes a process of referring questionable labeling to the relevant supervisory authority.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Haba Laboratories's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.